Hudson Capital Management LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudson Capital Management LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,576
-74.2%
11,9550.0%0.00%
-50.0%
Q2 2023$6,097
-19.1%
11,9550.0%0.00%
-33.3%
Q1 2023$7,532
-2.9%
11,9550.0%0.00%0.0%
Q4 2022$7,760
-63.0%
11,9550.0%0.00%
-70.0%
Q3 2022$21,000
+40.0%
11,9550.0%0.01%
+42.9%
Q2 2022$15,000
+87.5%
11,9550.0%0.01%
+133.3%
Q1 2022$8,000
-38.5%
11,9550.0%0.00%
-40.0%
Q4 2021$13,000
-40.9%
11,9550.0%0.01%
-44.4%
Q3 2021$22,000
-31.2%
11,9550.0%0.01%
-30.8%
Q2 2021$32,000
-25.6%
11,9550.0%0.01%
-27.8%
Q1 2021$43,000
+43.3%
11,9550.0%0.02%
+38.5%
Q4 2020$30,000
-99.9%
11,9550.0%0.01%
-13.3%
Q3 2020$30,127,000
+77148.7%
11,9550.0%0.02%
-28.6%
Q2 2020$39,000
+34.5%
11,9550.0%0.02%
+10.5%
Q1 2020$29,000
-48.2%
11,9550.0%0.02%
-32.1%
Q4 2019$56,000
-99.9%
11,9550.0%0.03%0.0%
Q3 2019$51,167,000
-22.0%
11,955
+6.2%
0.03%
-24.3%
Q2 2019$65,617,000
+51.4%
11,2550.0%0.04%
+42.3%
Q1 2019$43,332,000
+206242.9%
11,2550.0%0.03%
+73.3%
Q4 2018$21,000
-41.7%
11,2550.0%0.02%
-44.4%
Q3 2018$36,000
+5.9%
11,2550.0%0.03%
+12.5%
Q2 2018$34,000
-22.7%
11,2550.0%0.02%
-25.0%
Q1 2018$44,000
-6.4%
11,2550.0%0.03%
-5.9%
Q4 2017$47,00011,2550.03%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders